https://www.indianpharmapost.com/charsires-new-drug-aims-to-capture-dementia-treatment-market-130472022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/jb-pharma-witness-20-growth-in-august-2022-iqvia-130482022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/aster-hospitals-bangalore-launches-aster-international-institute-of-oncology-130492022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/bridgebio-pharma-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-fosdenopterin-130502022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/aster-pharmacy-forays-into-bangladesh-130512022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/reasons-for-the-surge-in-m-a-in-healthcare-and-pharmaceutical-sectors-in-india-ankit-poddar-navroz-mahudawala-candle-partners-130522022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-launches-lenalidomide-capsules-130532022-09-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-receives-tentative-approval-for-tenofovir-alafenamide-tablets-130542022-09-22T00:00:00+05:30always0.9